1,2-DIBROMOTETRACHLOROETHANE

Unipharm pharmaceutical industry Co., Ltd is a high-tech enterprise mainly engaged in R&D, production, sales and synthesis of APIs and pharmaceutical intermediates. Unipharm is committed to the research and development of advanced chemical technology. At present, our research achievement in the field of chiral technology, nitrogen-containing heterocyclic derivatives, halogen organic compounds, boric acid and its derivatives have reached the international advanced level. Our head office of UNIBROM has four production plants, one testing service company, one R&D center, one quality management center and three overseas companies. Relying on the global business vision, the industry-leading R&D platform and the perfect testing process, Unipharm continuously introduces new products and rapidly realizes large-scale production. Unipharm always keeps pace with the world pharmaceutical intermediates industry. Unipharm's clients include R&D laboratories in research institutes of universities and colleges, as well as commercial-scale companies in the pharmaceutical, biotechnology, chemical/petrochemical industries, and sales worldwide. Unipharm has a multi-functional pilot plant that meets GMP standards, a perfect quality control system, and introduces advanced analytical and testing equipment from around the world, including LC-MS, GC-MS, ICP-MS, HPLC, GC and a 400 MHz nuclear magnetic resonance (NMR) instrument used in conjunction with third-party platforms ensure that each product is subjected to stringent quality control. Unipharm has a group of high-quality management team and R&D talents, strong technical force, and has established close cooperative relations with several key university laboratories and research institutions at domestic and overseas. It has formed a production capacity from small test, pilot test to industrial scale, and fully meets the needs of custom synthesis and synthetic outsourcing production.